105 related articles for article (PubMed ID: 30997226)
1. Could WNT inhibitors really knock on the treatment door of small cell lung cancer?
Esteller L; Hernández S; Lopez-Rios F; Remon J
J Thorac Dis; 2019 Mar; 11(Suppl 3):S381-S384. PubMed ID: 30997226
[No Abstract] [Full Text] [Related]
2. Suppression of PPN/MG61 attenuates Wnt/beta-catenin signaling pathway and induces apoptosis in human lung cancer.
Chen Z; Li J; Li QS; Fan JQ; Dong XM; Xu JP; Wang XM; Yang GW; Yan P; Wen GZ; Zhang YT; Niu RG; Nan PH; He J; Zhou HM
Oncogene; 2008 May; 27(24):3483-8. PubMed ID: 18193088
[TBL] [Abstract][Full Text] [Related]
3. Wnt signaling as potential therapeutic target in lung cancer.
Yang J; Chen J; He J; Li J; Shi J; Cho WC; Liu X
Expert Opin Ther Targets; 2016 Aug; 20(8):999-1015. PubMed ID: 26882052
[TBL] [Abstract][Full Text] [Related]
4. TGF-β-induced profibrotic signaling is regulated in part by the WNT receptor Frizzled-8.
Spanjer AI; Baarsma HA; Oostenbrink LM; Jansen SR; Kuipers CC; Lindner M; Postma DS; Meurs H; Heijink IH; Gosens R; Königshoff M
FASEB J; 2016 May; 30(5):1823-35. PubMed ID: 26849959
[TBL] [Abstract][Full Text] [Related]
5. AZ1366: An Inhibitor of Tankyrase and the Canonical Wnt Pathway that Limits the Persistence of Non-Small Cell Lung Cancer Cells Following EGFR Inhibition.
Scarborough HA; Helfrich BA; Casás-Selves M; Schuller AG; Grosskurth SE; Kim J; Tan AC; Chan DC; Zhang Z; Zaberezhnyy V; Bunn PA; DeGregori J
Clin Cancer Res; 2017 Mar; 23(6):1531-1541. PubMed ID: 27663586
[No Abstract] [Full Text] [Related]
6. Wnt signaling pathway in non-small cell lung cancer.
Stewart DJ
J Natl Cancer Inst; 2014 Jan; 106(1):djt356. PubMed ID: 24309006
[TBL] [Abstract][Full Text] [Related]
7. Fluvastatin-mediated down-regulation of SATB1 affects aggressive phenotypes of human non-small-cell lung cancer cell line H292.
Xu HY; Xue JX; Gao H; Na FF; Li H; Zhang T; Lu Y
Life Sci; 2019 Apr; 222():212-220. PubMed ID: 30557545
[TBL] [Abstract][Full Text] [Related]
8. Wnt signaling regulates the stemness of lung cancer stem cells and its inhibitors exert anticancer effect on lung cancer SPC-A1 cells.
Zhang X; Lou Y; Wang H; Zheng X; Dong Q; Sun J; Han B
Med Oncol; 2015 Apr; 32(4):95. PubMed ID: 25731617
[TBL] [Abstract][Full Text] [Related]
9. TC-1 (c8orf4) enhances aggressive biologic behavior in lung cancer through the Wnt/β-catenin pathway.
Su K; Huang L; Li W; Yan X; Li X; Zhang Z; Jin F; Lei J; Ba G; Liu B; Wang X; Wang Y
J Surg Res; 2013 Nov; 185(1):255-63. PubMed ID: 23880650
[TBL] [Abstract][Full Text] [Related]
10. SOX9 regulated proliferation and apoptosis of human lung carcinoma cells by the Wnt/β-catenin signaling pathway.
Guo YZ; Xie XL; Fu J; Xing GL
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4898-4907. PubMed ID: 30070325
[TBL] [Abstract][Full Text] [Related]
11. Effect of nitric oxide synthase on multiple drug resistance is related to Wnt signaling in non-small cell lung cancer.
Li Y; Ma C; Shi X; Wen Z; Li D; Sun M; Ding H
Oncol Rep; 2014 Oct; 32(4):1703-8. PubMed ID: 25070480
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of Resistance and Novel Targets Mediating Resistance to EGFR and c-Met Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.
Botting GM; Rastogi I; Chhabra G; Nlend M; Puri N
PLoS One; 2015; 10(8):e0136155. PubMed ID: 26301867
[TBL] [Abstract][Full Text] [Related]
13. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
[TBL] [Abstract][Full Text] [Related]
14. Wnt inhibitory factor inhibits lung cancer cell growth.
Kim J; You L; Xu Z; Kuchenbecker K; Raz D; He B; Jablons D
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):733-7. PubMed ID: 17320573
[TBL] [Abstract][Full Text] [Related]
15. Ape1 regulates WNT/β-catenin signaling through its redox functional domain in pancreatic cancer cells.
Jiang S; Zhu L; Tang H; Zhang M; Chen Z; Fei J; Han B; Zou GM
Int J Oncol; 2015 Aug; 47(2):610-20. PubMed ID: 26081414
[TBL] [Abstract][Full Text] [Related]
16. Roles of Wnt/β-Catenin Signaling Pathway Regulatory Long Non-Coding RNAs in the Pathogenesis of Non-Small Cell Lung Cancer.
Lin S; Zhen Y; Guan Y; Yi H
Cancer Manag Res; 2020; 12():4181-4191. PubMed ID: 32581590
[TBL] [Abstract][Full Text] [Related]
17. A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma.
Tammela T; Sanchez-Rivera FJ; Cetinbas NM; Wu K; Joshi NS; Helenius K; Park Y; Azimi R; Kerper NR; Wesselhoeft RA; Gu X; Schmidt L; Cornwall-Brady M; Yilmaz ÖH; Xue W; Katajisto P; Bhutkar A; Jacks T
Nature; 2017 May; 545(7654):355-359. PubMed ID: 28489818
[TBL] [Abstract][Full Text] [Related]
18. Network of WNT and other regulatory signaling cascades in pluripotent stem cells and cancer stem cells.
Katoh M
Curr Pharm Biotechnol; 2011 Feb; 12(2):160-70. PubMed ID: 21044011
[TBL] [Abstract][Full Text] [Related]
19. Potent in vivo lung cancer Wnt signaling inhibition via cyclodextrin-LGK974 inclusion complexes.
Guimaraes PPG; Tan M; Tammela T; Wu K; Chung A; Oberli M; Wang K; Spektor R; Riley RS; Viana CTR; Jacks T; Langer R; Mitchell MJ
J Control Release; 2018 Nov; 290():75-87. PubMed ID: 30290244
[TBL] [Abstract][Full Text] [Related]
20. Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression.
Uematsu K; He B; You L; Xu Z; McCormick F; Jablons DM
Oncogene; 2003 Oct; 22(46):7218-21. PubMed ID: 14562050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]